Edgewise Therapeutics Inc (EWTX)

NASDAQ
17.51
-2.00(-10.25%)
After Hours
17.51
0.00(0.00%)
- Real-time Data
  • Volume:
    64,482
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    16.95 - 19.81

EWTX Overview

Prev. Close
19.51
Day's Range
16.95-19.81
Revenue
-
Open
19.47
52 wk Range
16.95-40.49
EPS
-
Volume
64,482
Market Cap
862.44M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
209,029
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
49,254,311
Next Earnings Date
Dec 01, 2021
What is your sentiment on Edgewise Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Edgewise Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsSellStrong SellStrong SellStrong SellBuy
SummarySellStrong SellStrong SellStrong SellNeutral

Edgewise Therapeutics Inc Company Profile

Edgewise Therapeutics Inc Company Profile

Sector
Services
Employees
19

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The Company is principally focused on discovering, developing and commercializing treatments for rare muscle disorders. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The Company's lead candidate, EDG-5506, is an orally administered allosteric, selective, fast myofiber (type II) myosin small molecule inhibitor designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). The Company's research programs include EDG-6289, EDG-002 and EDG-003.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.